UP

Pfizer has withdrawn a drug at risk for cancer

Home page Health
12 Punto 14 Punto 16 Punto 18 Punto
Pfizer has withdrawn a drug at risk for cancer

Pfizer has dropped the anti-cancer drug Chantix due to the risk of cancer.

Axar.az reports this step was taken due to the high content of cancer-causing substances in the pills.

Experts from the Food and Drug Administration of the US Department of Health and Human Services have come to this conclusion.

Studies show that long-term use of the drug increases the risk of cancer.

Date
2021.09.19 / 18:31
Author
Axar.az
See also

Avoid alcohol in autumn to protect your immunity

Uzbek, Kazakh doctors perform robotic surgery in Tashkent

WHO warns of dangerous India-made cough syrups

Azerbaijan receives Sanofi influenza vaccines

Scientists develop a drug that trains the immune system

Early smoking increases cancer risk up to 4 times

Chikungunya fever is spreading rapidly in South China

Harmanci: COVID-19 still present, caution needed

Millions at risk as US ends AIDS funding - UNAIDS report

Smart hydrogel developed to heal chronic wounds faster

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla